Alaska Native Tribal Health Consortium
Anchorage, Alaska, 99508, United States
Location status: Recruiting
Location contact
Barb J Stillwater, PhD
CONTACT
Timothy K Thomas, MD
CONTACT
NCT Number: NCT06556433
The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Anchorage, Alaska, 99508, United States
Location status: Recruiting
Barb J Stillwater, PhD
CONTACT
Timothy K Thomas, MD
CONTACT
Dyads will be stratified by the index participant's sex, and residence with family member, and by the family member's current smoking status then randomized to a no incentives control condition (n=328 dyads) or a 6-month incentive intervention (n=328 dyads).
All dyads will receive existing evidence-based cessation materials on treatment resources and social support strategies. The study will measure the index participant's smoking status in both study groups weekly during the first four weeks, and at three and six months. All participants, including support persons, will receive incentives when they complete each of the smoking status assessments. The intervention group will additionally receive individual rewards provided to the index participant for achieving verified smoking abstinence at each time point, to a maximum of $750.
The enrolled family member will also receive rewards equivalent to the value earned by the index participant that can contribute to family needs. The study will explore potential moderators (e.g., family member smoking status, index participant's sex) and mediators (e.g., interdependence) of intervention effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Index Participant Inclusion Criteria:
Index Participant Exclusion Criteria:
Family Member Participant Inclusion Criteria (regardless of smoking status or residence with the index participant):
Both men and women, those from non-ANAI racial/ethnic groups, and those who live outside of Alaska in the United States will be eligible family member participants.
Family Member Participant Exclusion Criteria:
After the randomized controlled trial, qualitative interviews will be conducted with index participants, family member participants, and Alaska Tribal Health System Stakeholders to inform program implementation. Healthcare providers, cessation specialists, Elder advisors, and Tribal Health System leaders and stakeholders will be invited by the Alaska Native Tribal Health Consortium team and separately consented and interviewed.
Participants in the Rewards Group will have abstinence reinforced through escalating financial incentives.
Time frame: 6 months, 12 months
Number of participants to have biochemically verified, prolonged smoking abstinence.
Contact information is provided by the study sponsor or research team.
Audrey G McGuinness, BA
CONTACT
Christi A Patten, PhD
CONTACT
Mayo Clinic
Other
Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: An RCT
Acronym: Aniqsaaq-RCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585357
Behavior, Health Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06584929
Behavior, Health Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT07166120
Behavior, Health Behavior
St Louis, Missouri, United States
View Trial DetailsNCT06651684
Behavior, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial Details